Hirota Nami, Edskes Herman, Hall Damien
Do International Trading House, Koshienguchi-1-chome, Nishinomiya, Hyogo, 6113, Japan.
Laboratory of Biochemistry and Genetics, NIDDK, NIH, Bld 8, Bethesda, MD, 20892-0830, USA.
Biophys Rev. 2019 Apr;11(2):191-208. doi: 10.1007/s12551-019-00506-5. Epub 2019 Mar 19.
Solution conditions chosen for the production of amyloid can also promote formation of significant extents of amorphous protein aggregate. In one interpretation, the amyloid and amorphous aggregation pathways are considered to be in competition with each other. An alternative conceptualization involves considering amorphous aggregation as an obligatory intermediate process of the amyloid formation pathway. Here, we review recently developed macroscopic-level theories of protein aggregation that unify these two competing models into a single paradigm. Key features of the unified model included (1) a description of the amorphous aggregate as a second liquid phase with the degree of liquid-like character determined by the mobility of the monomer within it, and (2) heterogeneous growth pathways based on nucleation, growth, and fragmentation of amyloid occurring within different phases and at their interfacial boundary. Limiting-case behaviors of the protein aggregation reaction, either singly involving amyloid or amorphous aggregate production, and mixed-case behaviors, involving competitive and/or facilitated growth of amorphous and amyloid species, are presented and reviewed in context. This review principally describes an approach developed by Hirota and Hall 2019 (Hirota, N. and Hall, D. 2019. Protein Aggregation Kinetics: A Unified Theoretical Description. Chapter 7 of 'Protein Solubility and Amorphous Aggregation: From Academic Research to Applications in Drug Discovery and Bioindustry' edited by Y. Kuroda and F. Arisaka. CMC Publishers). Sections of that work are translated from the original Japanese and republished here with the full permission of CMC Publishing Corporation.
为生成淀粉样蛋白而选择的溶液条件也可能促进大量无定形蛋白质聚集体的形成。一种解释是,淀粉样蛋白和无定形聚集途径被认为是相互竞争的。另一种概念化方式是将无定形聚集视为淀粉样蛋白形成途径中一个必不可少的中间过程。在这里,我们回顾了最近发展起来的蛋白质聚集宏观层面理论,这些理论将这两种相互竞争的模型统一到一个单一的范式中。统一模型的关键特征包括:(1)将无定形聚集体描述为第二液相,其类液体特征程度由其中单体的流动性决定;(2)基于在不同相及其界面边界处发生的淀粉样蛋白的成核、生长和碎片化的异质生长途径。本文阐述并回顾了蛋白质聚集反应的极限情况行为,包括单独涉及淀粉样蛋白生成或无定形聚集体生成的情况,以及混合情况行为,即涉及无定形和淀粉样蛋白物种的竞争性和/或促进性生长。本综述主要描述了Hirota和Hall在2019年提出的一种方法(Hirota, N.和Hall, D. 2019. Protein Aggregation Kinetics: A Unified Theoretical Description. 收录于由Y. Kuroda和F. Arisaka编辑的《Protein Solubility and Amorphous Aggregation: From Academic Research to Applications in Drug Discovery and Bioindustry》第7章。CMC出版社)。该著作的部分内容从原始日语翻译而来,并经CMC出版公司完全许可在此重新发布。